Drug Type Prophylactic vaccine, Genetically engineered subunit vaccine |
Synonyms WSK-V102D, 威克欣 XBB |
Target |
Action inhibitors |
Mechanism SARS-CoV S protein inhibitors(SARS-CoV S protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jun 2023), |
RegulationEmergency Use Authorization (China) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
COVID-19 | China | 01 Jun 2023 |